Dynamics of immunotherapy antitumor models with impulsive control strategy

[1]  V. Lakshmikantham,et al.  Theory of Impulsive Differential Equations , 1989, Series in Modern Applied Mathematics.

[2]  Karolina Palucka,et al.  Cancer immunotherapy via dendritic cells , 2012, Nature Reviews Cancer.

[3]  Ben Niu,et al.  Hopf Bifurcation Induced by Delay Effect in a Diffusive Tumor-Immune System , 2018, Int. J. Bifurc. Chaos.

[4]  Y. Takeuchi,et al.  Dynamical behavior of combinational immune boost against tumor , 2015 .

[5]  S. Ruan.  Nonlinear dynamics in tumor-immune system interaction models with delays , 2021 .

[6]  Jianjun Paul Tian,et al.  The replicability of oncolytic virus: defining conditions in tumor virotherapy. , 2011, Mathematical biosciences and engineering : MBE.

[7]  A. Radunskaya,et al.  Mixed Immunotherapy and Chemotherapy of Tumors: Modeling, Applications and Biological Interpretations , 2022 .

[8]  C. Parish.  Cancer immunotherapy: The past, the present and the future , 2003, Immunology and cell biology.

[9]  Y. Takeuchi,et al.  Mathematical modeling and analysis of combinational immune boost for tumor elimination , 2016 .

[10]  D. Earn,et al.  Interactions Between the Immune System and Cancer: A Brief Review of Non-spatial Mathematical Models , 2011, Bulletin of mathematical biology.

[11]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[12]  Zeljko Bajzer,et al.  Modeling of cancer virotherapy with recombinant measles viruses. , 2008, Journal of theoretical biology.

[13]  Jianjun Paul Tian,et al.  Modeling the effects of resection, radiation and chemotherapy in glioblastoma , 2009, Journal of Neuro-Oncology.

[14]  Junjie Wei,et al.  Lytic cycle: A defining process in oncolytic virotherapy , 2013 .

[15]  A. Perelson,et al.  Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis. , 1994, Bulletin of mathematical biology.

[16]  S. Rosenberg,et al.  Adoptive cell transfer: a clinical path to effective cancer immunotherapy , 2008, Nature Reviews Cancer.

[17]  Weihua Jiang,et al.  Impulsive perturbations in a predator–prey model with dormancy of predators , 2014 .

[18]  Sanyi Tang,et al.  Optimum timing for integrated pest management: modelling rates of pesticide application and natural enemy releases. , 2010, Journal of theoretical biology.

[19]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[20]  R. Boidot,et al.  Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination , 2019, Journal of Immunotherapy for Cancer.

[21]  Shigui Ruan,et al.  Bifurcation analysis in models of tumor and immune system interactions , 2009 .

[22]  Dongxi Li,et al.  Stochastic responses of tumor–immune system with periodic treatment , 2017 .

[23]  Manish R. Sharma,et al.  Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  D. Kirschner,et al.  Modeling immunotherapy of the tumor – immune interaction , 1998, Journal of mathematical biology.

[25]  Ping Bi,et al.  Bifurcations in Delay Differential Equations and Applications to Tumor and Immune System Interaction Models , 2013, SIAM J. Appl. Dyn. Syst..

[26]  A. Friedman,et al.  Modeling combination therapy for breast cancer with BET and immune checkpoint inhibitors , 2018, Proceedings of the National Academy of Sciences.

[27]  T. Tian,et al.  Mathematical modeling and analysis of tumor-volume variation during radiotherapy , 2021 .

[28]  Xinan Zhang,et al.  Dynamic analysis of an antitumor model and investigation of the therapeutic effects for different treatment regimens , 2017 .